US states step in to regulate reprocessors of single-use devices in view of FDA "policy vacuum"
This article was originally published in Clinica
The FDA is facing renewed pressure from industry over its refusal to take regulatory action against the third party processing of single-use devices. The US Medical Device Manufacturers Association (MDMA) said last week that it is contemplating a lawsuit or legislation if the FDA refuses to act on the issue soon.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.